Health disparities in the immunoprevention of human papillomavirus infection and associated malignancies
AH Bakir, M Skarzynski - Frontiers in Public Health, 2015 - frontiersin.org
Human papillomavirus (HPV) causes roughly 1.6% of the plus 1.6 million cases of cancer
that are diagnosed in the United States each year. Despite the proven safety and efficacy of …
that are diagnosed in the United States each year. Despite the proven safety and efficacy of …
Racial and ethnic disparities in human papillomavirus‐associated cancer burden with first‐generation and second‐generation human papillomavirus vaccines
BACKGROUND In the United States, the burden of human papillomavirus (HPV)‐associated
cancers varies by racial/ethnic group. HPV vaccination may provide opportunities for primary …
cancers varies by racial/ethnic group. HPV vaccination may provide opportunities for primary …
[HTML][HTML] Elimination of cancer health disparities through the acceleration of HPV vaccines and vaccinations: a simplified version of the president's cancer panel report …
E McGhee, H Harper, A Ume, M Baker… - Journal of vaccines & …, 2017 - ncbi.nlm.nih.gov
The human papillomavirus (HPV) is a major public health concern affecting both females
and males. HPV is associated with cervical, anal, head and neck cancers. About 99% of all …
and males. HPV is associated with cervical, anal, head and neck cancers. About 99% of all …
Human Papillomavirus Vaccines
D Saslow, CM Wheeler - Ethnicity & Disease, 2007 - JSTOR
The availability of a prophylactic human papillomavirus (HPV) vaccine for the prevention of
cervical cancer and its precursors offers the potential to reduce cervical cancer incidence …
cervical cancer and its precursors offers the potential to reduce cervical cancer incidence …
Demographic Influences on Adult HPV Vaccination: Results from a Cross-Sectional Survey in Tennessee
A Cernasev, O Oyedeji, CM Springer, TM Hagemann… - Healthcare, 2024 - mdpi.com
HPV is the most prevalent sexually transmitted infection in the US, with more than 80% of all
Americans contracting it by age 45. Effective vaccines for HPV exist and were recently …
Americans contracting it by age 45. Effective vaccines for HPV exist and were recently …
Overcoming barriers to low HPV vaccine uptake in the United States: recommendations from the National Vaccine Advisory Committee: approved by the National …
National Vaccine Advisory … - Public Health Reports, 2016 - journals.sagepub.com
An average of 25,900 cases of human papillomavirus (HPV)-associated cancers are newly
diagnosed in the United States each year. 1, 2 An estimated 14 million people are newly …
diagnosed in the United States each year. 1, 2 An estimated 14 million people are newly …
Preventing cervical cancer in the United States: barriers and resolutions for HPV vaccination
AL Beavis, KL Levinson - Frontiers in Oncology, 2016 - frontiersin.org
Human papillomavirus (HPV) vaccination rates for preadolescent and adolescent girls in the
United States are far behind those of other developed nations. These rates differ …
United States are far behind those of other developed nations. These rates differ …
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy
EL Franco, S de Sanjosé, TR Broker, MA Stanley… - Vaccine, 2012 - Elsevier
The recognition that human papillomavirus (HPV) infection is the central, necessary cause of
cervical cancer paved the way to new fronts of prevention via improved screening methods …
cervical cancer paved the way to new fronts of prevention via improved screening methods …
Barriers to Human Papillomavirus Vaccination Initiation and Completion among Adults Aged 18–26 Years in a Large Healthcare System
L Khalil, E Russo, K Venkatakrishnan, AL Mazul… - Cancers, 2023 - mdpi.com
Simple Summary This study investigated HPV vaccination rates and associated factors
among 265,554 patients aged 18–26 within a large healthcare system. Alarmingly, only 30 …
among 265,554 patients aged 18–26 within a large healthcare system. Alarmingly, only 30 …
Human papillomavirus vaccines: successes and future challenges
Over a decade has passed since the first human papillomavirus (HPV) vaccine was
introduced. These vaccines have received unequivocal backing from the scientific and …
introduced. These vaccines have received unequivocal backing from the scientific and …